Sweden's Getinge in cash deal for Datascope valued at $865 million

September 2008
Medical Device Daily;9/17/2008, Vol. 12 Issue 199, p1
The article reports on the acquisition of Datascope by Getinge, a Swedish medical-technology company with operations in the cardiac surgery and vascular surgery markets. According to Getinge, it wants to build its cardiovascular division into a world leading business which is focused on cardiac surgery, vascular intervention and cardiac assist. It adds that the acquisition of Datascope represents a strong addition to its product portfolio as well as its sales organization.


Related Articles

  • Deals roundup.  // Medical Device Daily;11/5/2008, Vol. 12 Issue 216, p8 

    This article reports on the second request received by Datascope from the U.S. Federal Trade Commission (FTC) for additional information concerning Getinge's proposed acquisition of the company. Both companies plan to cooperate with the FTC as the agency conducts its review of the proposed...

  • Deals roundup.  // Medical Device Daily;12/12/2008, Vol. 12 Issue 221, p4 

    The article reports on the announcement by Getinge that it will extend its previously reported $53 per share cash tender offer for all of the outstanding shares of Datascope until midnight of January 6, 2009, as such time may be extended. It added that all other terms and conditions of the offer...

  • Datascope to sell EVH product to Sorin after Getinge merger.  // Medical Device Daily;12/1/2008, Vol. 12 Issue 232, p4 

    The article reports on the decision of Datascope to sell its endoscopic vessel harvesting (EVH) product line to Sorin Group. The transaction is contingent on the closing of the acquisition of Datascope by Getinge as well as the satisfaction of other typical conditions. It was reported in...

  • Deals roundup.  // Medical Device Daily;11/6/2008, Vol. 12 Issue 217, p4 

    The article reports that Getinge has extended its previously disclosed $53 per share cash tender offer for all the outstanding shares of Datascope until 12 midnight of November 11, 2008. Data on the shares of Datascope common stock that had been validly tendered and not withdrawn in the offer is...

  • Datascope inquiry focuses on its acquisition by Getinge.  // Medical Device Daily;9/19/2008, Vol. 12 Issue 201, p5 

    The article reports on an inquiry on Getinge's acquisition of Datascope for $865 million cash. The board of directors of Datascope are being investigated by law firm Levi & Korsinsky for fiduciary duty breaches and other violations of the state law in New Jersey. Under the terms of the...

  • Deals roundup.  // Medical Device Daily;1/15/2009, Vol. 13 Issue 9, p3 

    The article reports on the decision of Getinge AB to extend its previously reported $53 a share cash tender offer for all of the outstanding shares of Datascope until the end of January 21, 2009. The company noted that other terms of the deal were unchanged. First reported in September 2008, the...

  • CORPORATE.  // MondayMorning;9/22/2008, Vol. 16 Issue 37, p2 

    The article reports updates related to health industry in New Jersey. Getinge AB plans to buy Datascope Corp. for $865 million in cash with a 7.7% premium price over the closing share. King Pharmaceuticals Inc. sued its rival to invalidate a poison-pill takeover defense. Wyeth Inc.'s...

  • Acquisitions.  // Cardiovascular Devices & Drugs;Dec2008, Vol. 14 Issue 12, p23 

    This section offers news briefs on acquisitions in the cardiovascular devices and drugs industries. Replidyne will merge with Cardiovascular Systems (CSI), a company developing interventional systems for vascular disease, in an all-stock deal. The Federal Trade Commission (FTC) is seeking...

  • Deals.  // Medical Device Daily;1/10/2008, Vol. 12 Issue 7, p3 

    The article reports on the completion of the sale of Boston Scientific's cardiac and vascular surgery business to Swedish company Getinge Group for $750 million in cash. According to Getinge, it would use the acquisition to establish a base for building a global cardiac surgery business. An...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics